Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Adjuvant treatments for resectable pancreatic cancer
Hideki Ueno
, Tomoo Kosuge
Research output
:
Contribution to journal
›
Review article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adjuvant treatments for resectable pancreatic cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adjuvant Therapy
100%
Borderline Resectable Pancreatic Cancer
100%
Pancreatic Cancer
50%
United States
25%
Clinical Trials
25%
Malignancy
25%
Randomized Controlled Trial
25%
Chemotherapy
25%
Surgical Resection
25%
Resection
25%
Adjuvant Chemotherapy
25%
Recurrence Rate
25%
Gemcitabine
25%
Survival Rate
25%
Chemoradiotherapy
25%
Chemotherapy Alone
25%
After Surgery
25%
Europe
25%
Advanced Cancer
25%
Optimal Therapy
25%
Radiation Therapy Oncology Group
25%
Japanese Studies
25%
Medicine and Dentistry
Adjuvant Therapy
100%
Pancreas Cancer
100%
Diseases
50%
Chemotherapy
50%
Clinical Trial
25%
Cancer
25%
Randomized Controlled Trial
25%
Adjuvant Chemotherapy
25%
Survival Rate
25%
Gemcitabine
25%
Chemoradiotherapy
25%
Recurrence Risk
25%
Cancer Staging
25%
Oncology
25%
Radiation Therapy
25%